Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-028919

REATA PHARMACEUTICALS INC · RETA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
William Rose
Director · 10% Owner · Other
Charles E. Gale
10% Owner · Other
Evelyn P. Rose
10% Owner · Other
Period of report
Nov 13, 2018
Accepted (ET)
Nov 14, 2018 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockF3Nov 13, 2018J811,546$0.00D0IBy Puffin
Class A Common StockF4Nov 13, 2018J811,546$0.00A879,281IBy trust
Class A Common StockF5holding———11,618D
Class A Common StockF6holding———7,886ISee Footnote
Class A Common StockF7holding———20IBy trust
Class A Common StockF8holding———45IBy trust
Class A Common StockF9holding———13,517D
Class A Common StockF10holding———29ISee Footnote
Class A Common StockF11holding———180,909IBy Montrose

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

The reporting persons may be deemed to be members of a group with other affiliated entities that collectively are 10% owners, which group includes William E. Rose, Evelyn P. Rose, Evelyn P. Rose Fidelity Rollover IRA, Evelyn Potter Rose Survivor's Trust, Charles Henry Rose 2001 Trust, John William Rose 2002 Trust, Charles E. Gale, Charles E. Gale Fidelity Rollover IRA, Puffin Partners, L.P., Puffin GP, LLC, Montrose Investments I, L.P. and Montrose Investments GP, LLC (collectively, the "Affiliated Rose Reporting Persons"). As a result of the transaction reported in this Form 4, Puffin Partners, L.P. and Puffin GP, LLC are exiting the group. The reporting persons disclaim the existence of a group and disclaim beneficial ownership of any securities held by the other Affiliated Rose Reporting Persons, except to the extent of their respective pecuniary interests therein. Form 1 of 2.